Jumo Health任命布里特妮·埃拉纳为首席执行官，领导下一阶段的增长-动脉网

Jumo Health Appoints Brittany Erana Chief Executive Officer to Lead Next Phase of Growth

CISION 等信源发布 2025-06-02 21:30



可切换为仅中文







Erana joins the award-winning clinical trial solutions company to build patient-first solutions that accelerate study participation

埃拉娜加入这家荣获奖项的临床试验解决方案公司，致力于构建以患者为中心的解决方案，加速研究参与。

NEW HAVEN, Conn.

康涅狄格州纽黑文

，

June 2, 2025

2025年6月2日

/PRNewswire/ --

Jumo Health

卓睦健康

, a global leader in optimizing the patient experience in clinical trials, today announced the appointment of Brittany Erana as Chief Executive Officer. With more than 20 years of experience in digitally enabled research and patient-centered innovation, Erana will lead the company's next stage of strategic growth focused on increasing patient activation and reducing trial dropout rates..

，一家全球领先的优化临床试验患者体验的公司，今天宣布任命布里塔尼·埃拉纳为首席执行官。埃拉纳在数字赋能研究和以患者为中心的创新方面拥有超过20年的经验，她将带领公司进入下一阶段的战略增长，专注于提高患者参与度并降低试验退出率。

Prior to joining Jumo Health, Erana served as General Manager of patient first digital solutions at PPD, one of the world's leading contract research organizations. There, she oversaw digital transformation strategies that modernized clinical research operations, enhanced patient experience, and improved data collection..

在加入Jumo Health之前，Erana曾担任全球领先的合同研究组织之一PPD的患者优先数字解决方案总经理。在那里，她监督了现代化临床研究操作、提升患者体验和改进数据收集的数字化转型战略。

'Building the future of healthcare with the patient at the center has been the throughline of my career,' said Erana. 'I'm thrilled to be joining Jumo Health at this pivotal moment to help transform how people are engaged in clinical research from first touch to final visit, and improving how our clients bring new therapies to market for those who need them most.'.

“以患者为中心构建医疗保健的未来一直是我职业生涯的主线，”埃拉娜说道。“我很激动能在这一关键时刻加入Jumo Health，帮助转变人们从首次接触到最终访问参与临床研究的方式，并改善我们的客户将新疗法带给最需要它们的患者的方式。”

Erana will be responsible for guiding Jumo Health through a dynamic phase of growth and transformation in partnership with Falfurrias Management Partners, who acquired Jumo Health in

埃拉娜将负责引导朱莫健康度过一个与法尔弗里亚斯管理合伙人合作的动态增长和转型阶段，后者收购了朱莫健康。

August 2024

2024年8月

. Her focus will be on expanding Jumo Health's capabilities through organic and acquisitive growth opportunities, enabling the company to address key friction points in trial awareness, accessibility, and adherence, especially for underrepresented patient populations.

她的工作重点将是通过有机增长和收购增长机会来扩展Jumo Health的能力，使公司能够解决试验意识、可及性和依从性的关键摩擦点，特别是对于代表性不足的患者群体。

'As trial dropout rates rise, protocol complexity increases, and timelines lengthen, sponsors need more than study awareness campaigns; they need personalized, scalable patient experience solutions,' said Adam Cossman, Jumo Health's Executive Chairman and an executive advisor on the Falfurrias team.

“随着试验脱落率上升、方案复杂性增加以及时间线延长，申办方需要的不仅仅是研究宣传运动；他们需要个性化、可扩展的患者体验解决方案，”Jumo Health的执行主席兼Falfurrias团队的执行顾问亚当·科斯曼表示。

'Brittany's leadership will be pivotal in meeting this need and building upon Jumo Health's legacy in clinical innovation.'.

“布列塔尼的领导对于满足这一需求并延续Jumo Health在临床创新方面的传承将起到关键作用。”

About Jumo Health

关于Jumo Health

Jumo Health (

www.jumohealth.com

) is the global leader in patient experience optimization, leveraging behavioral science, health literacy, and creative storytelling to drive informed participation in clinical trials. We enable patients to uncover the information they need, in the formats they desire, accessed via the channels they prefer, to become active clinical trial participants.

）是患者体验优化的全球领导者，利用行为科学、健康素养和创意叙事来推动临床试验的知情参与。我们帮助患者以他们希望的格式、通过他们偏好的渠道获取所需信息，从而成为积极的临床试验参与者。

Spanning 24 therapeutic areas and 180 conditions in 90 languages, our human-centered educational solutions are the choice of 17 of the world's top 25 life sciences companies to help them reduce stigma, eliminate fear, and build trust with target patient populations, including those which are historically underrepresented.

涵盖24个治疗领域和180种疾病，使用90种语言，我们以人为本的教育解决方案被世界前25家生命科学公司中的17家选中，帮助它们减少病耻感、消除恐惧，并与目标患者群体建立信任，其中包括历史上代表性不足的群体。

By creating accessible, relevant, and impactful communications, we empower patients to take charge of their health, remove barriers to clinical trial participation, and ultimately contribute to better outcomes..

通过创建无障碍、相关且有影响力的沟通，我们赋予患者掌控自身健康的能力，消除参与临床试验的障碍，并最终为更好的结果做出贡献。

About Falfurrias

关于法尔夫里亚斯

Falfurrias Capital Partners is an operationally focused middle-market private equity fund focused on investing in growth companies. The team is comprised of investors and proven operators, as well as in-house resources across strategy & market insights, risk & integration, talent, and technology. The fund is managed by Falfurrias Management Partners, a Charlotte-based private equity firm founded in 2006 by .

Falfurrias Capital Partners是一家专注于中型市场的企业运营型私募股权基金，致力于投资成长型公司。团队由投资者、经验丰富的运营者以及在战略与市场洞察、风险与整合、人才和技术方面的内部资源组成。该基金由总部位于夏洛特的私募股权公司Falfurrias Management Partners管理，该公司于2006年成立。

Hugh McColl Jr.

小休·麦科尔

, former chairman and CEO of Bank of America;

，美国银行前董事长兼首席执行官；

Marc Oken

马克·奥肯

, former CFO of Bank of America; and Managing Partner Ed McMahan. The firm has raised

，前美国银行首席财务官；以及管理合伙人埃德·麦克马汉。该公司已经筹集了

$3.6 billion

36亿美元

across seven funds and invests in growing, middle-market businesses in sectors where the firm's operational resources, relationships, and sector expertise can be employed to complement portfolio company executive teams in support of growth objectives. For more information, visit

横跨七只基金，投资于成长中的中型市场企业，这些企业的领域可以使公司的运营资源、关系和行业专长得以发挥作用，以支持组合公司高管团队实现增长目标。欲了解更多信息，请访问

www.falfurrias.com

。

SOURCE Jumo Health

来源：Jumo Health

WANT YOUR COMPANY'S NEWS

想要贵公司的新闻吗？

FEATURED ON PRNEWSWIRE.COM?

是否在PRNEWSWIRE.COM上展示？

440k+

44万+

Newsrooms &